At 10.8% CAGR, the Asia Pacific Poultry Diagnostic Market is Projected to be Worth US$ 289.42 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Asia Pacific poultry diagnostic market was valued at US$ 127.46 million in 2022 and is expected to reach US$ 289.42 million by 2030, registering a CAGR of 10.8% from 2022 to 2030.  Rising zoonotic disease cases and technological advancements attributed to the Asia Pacific poultry diagnostic market expansion.        

A report by Frontiers S.A. states disease control, high production, product quality, and reasonable production costs as among the main goals of the current poultry industry. Additionally, Assistance to State for Control of Animal Disease (ASCAD) aims to strategically control the prevention and eradication of different economically important diseases of livestock and poultry birds through six components. A few notable of these components include the strategic immunization of livestock and poultry for protecting economically important poultry diseases, and the modernization of existing labs or a new setup of disease diagnostic laboratories. Such government support and initiatives in diagnostics would offer lucrative market opportunities for poultry producers compared to simple diagnosis.

On the contrary, Insufficient welfare measures for poultry hampers the Asia Pacific poultry diagnostic market.  

Based on test type, the Asia Pacific poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (elisa) tests, polymerase chain reaction (pcr) tests, hemagglutination-inhibition (hi), and others. The enzyme-linked immunosorbent assay (elisa) tests segment held 45.8% share of Asia Pacific poultry diagnostic market in 2022, amassing US$ 58.35 million. It is projected to garner US$ 137.81 million by 2030 to expand at 11.3% CAGR during 2022–2030. 

In terms of disease, the Asia Pacific poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, newcastle disease, avian mycoplasmosis, and others. The avian influenza segment held 29.6% share of Asia Pacific poultry diagnostic market in 2022, amassing US$ 37.78 million. It is projected to garner US$ 87.65 million by 2030 to expand at 11.1% CAGR during 2022–2030.

By country, the Asia Pacific poultry diagnostic market has been categorized into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 67.7% share of Asia Pacific poultry diagnostic market in 2022. It was assessed at US$ 86.28 million in 2022 and is likely to hit US$  199.06 million by 2030, exhibiting a CAGR of 11.0% during 2022–2030.      

Key players operating the Asia Pacific poultry diagnostic market are Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, Bioneer Corp, among others.

• The Eurofins Scientific Inc company, In Aug-2021 expansion Eurofins BioDiagnostics (EBDI), a global leader in agroscience and genomics testing announced launching of a new animal health testing service offerings. The new testing services focusses on diagnostic testing and surveillance to detect swine diseases and has been designed to address the needs of producers that require rapid turn-around testing.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com